Clinical Research for Alzheimer's Disease
Have you or someone you love been diagnosed with Alzheimer’s Disease?
Radiant Research is participating in a nationwide study evaluating the effects of a once-a-day nutritional drink on individuals with mild-to-moderate Alzheimer’s Disease.
What is the purpose of this study?
The purpose of this study is to test whether a nutritional drink is effective and safe for the dietary management of Alzheimer’s Disease.
What will you be asked to do?
You will be asked to consume a nutrition drink once every day for a period of 6 months. During this time, you will be regularly monitored and tested by study staff for any changes in your memory and thinking abilities.
To be eligible to participate in this study, you must be:
Clinically diagnosed with mild-to-moderate Alzheimer’s Disease
Taking an FDA approved medication for Alzheimer’s Disease (Aricept, Exelon, Razadyne, and/or Namenda) for the past 4 months
50 years of age or older
Not previously diagnosed with vascular dementia, Huntington’s Disease, Parkinson’s Disease or seizures
Not living in a nursing home
Able to have a caregiver or study partner be with you during all study visits and telephone calls.
For more information or to volunteer, contact:
Dr. Eugene DuBoff, Radiant Research Denver
303.477.CARE (2273)
12015 E. 46th Ave., Suite 500, Denver,CO
|
|
Radiant Research | Denver |